These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 20846397)
1. Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer. Zhou Y; Zhou N; Fang W; Huo J Diagn Pathol; 2010 Sep; 5():58. PubMed ID: 20846397 [TBL] [Abstract][Full Text] [Related]
2. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma. Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma. Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671 [TBL] [Abstract][Full Text] [Related]
4. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
6. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells. Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525 [TBL] [Abstract][Full Text] [Related]
7. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer. Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979 [TBL] [Abstract][Full Text] [Related]
8. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma. Liu X; Ou H; Xiang L; Li X; Huang Y; Yang D Oncotarget; 2017 Feb; 8(6):10510-10522. PubMed ID: 28060737 [TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression. Gao W; Chen X; Chi W; Xue M Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222 [TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma. Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431 [TBL] [Abstract][Full Text] [Related]
11. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice. Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751 [TBL] [Abstract][Full Text] [Related]
12. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of HDGF Inhibits the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo. Enomoto H; Nakamura H; Liu W; Iwata Y; Nishikawa H; Takata R; Yoh K; Hasegawa K; Ishii A; Takashima T; Sakai Y; Aizawa N; Ikeda N; Iijima H; Nishiguchi S Anticancer Res; 2015 Dec; 35(12):6475-9. PubMed ID: 26637859 [TBL] [Abstract][Full Text] [Related]
14. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related]
15. Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma. Zhang B; Dong LW; Tan YX; Zhang J; Pan YF; Yang C; Li MH; Ding ZW; Liu LJ; Jiang TY; Yang JH; Wang HY Br J Cancer; 2013 Jul; 109(1):14-23. PubMed ID: 23764751 [TBL] [Abstract][Full Text] [Related]
16. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis. Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538 [TBL] [Abstract][Full Text] [Related]
17. Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells. Yang GY; Zhang AQ; Wang J; Li CH; Wang XQ; Pan K; Zhou C; Dong JH Cell Biochem Funct; 2016 Jun; 34(4):274-85. PubMed ID: 27273265 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression. Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells. Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209 [TBL] [Abstract][Full Text] [Related]
20. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]